Last edited by Duramar
Sunday, May 10, 2020 | History

5 edition of The Design of analgesic clinical trials found in the catalog.

The Design of analgesic clinical trials

  • 289 Want to read
  • 19 Currently reading

Published by Raven Press in New York .
Written in English

    Subjects:
  • Analgesics -- Testing,
  • Pain -- Chemotherapy,
  • Clinical trials -- Design,
  • Analgesics,
  • Clinical Trials -- methods,
  • Pain -- drug therapy

  • Edition Notes

    Includes bibliographical references and index.

    Statementeditors, Mitchell B. Max, Russell K. Portenoy, Eugene M. Laska.
    SeriesAdvances in pain research and therapy ;, v. 18
    ContributionsMax, Mitchell., Portenoy, Russell K., Laska, Eugene M., 1939-
    Classifications
    LC ClassificationsRM319 .D39 1991
    The Physical Object
    Paginationxxi, 729 p. :
    Number of Pages729
    ID Numbers
    Open LibraryOL1857129M
    ISBN 100881677361
    LC Control Number90009146

    Clinical Trials -- methods. Clinical trials -- Methods. Pain -- drug therapy. Analgesics -- Testing. Clinical Trials as Topic -- methods. Pain -- Drug therapy. Analgesics. Pain -- Chemotherapy. Clinical trials -- Design. Notes. Includes bibliographical references and index. Language. English ISBN. Dewey Number. // The FDA's Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Initiative aims to streamline the discovery and development process for new analgesic drug products for the benefit of the public health, and is being developed, in large part, as a public-private partnership (PPP), involving multiple .

    for large clinical trials. Experimental pain models have been established as cost-effective tools for assessing analgesic drug efficacy. However, their translation into new clinically effective compounds seems to be unsatisfactory (Mogil, ). The prediction of clinical efficacy of analgesics obtained in human pain modelsCited by: The objective of analgesic medication is to relieve discomfort and ameliorate the patient’s dissatisfaction with his/her overall clinical state related to pain. Because pain can be perceived only by the patients/subjects themselves, subjective patient reports are the only measures of pain intensity currently available.

    Design of Clinical Trials. Randomized controlled trials (RCTs), when correctly designed and rigorously conducted, provide the most definitive answers regarding intervention effects, but other clinical trial designs and observational investigations can be appropriately employed depending on resources and the specific questions of interest. 1 While nonrandomized experimental Cited by: 1. The Design of Analgesic Clinical Trials (Advances in Pain Research and Therapy, Vol. 18), Mitchell B. Max, Russell K. Portenoy, and Eugene M. Laska, Editors. Patient Compliance in Medical Practice and Clinical Trials, Joyce A. Cramer and Bert Spilker, Editors. Clinical Drug Therapy, Anne Abrams, Editor.


Share this book
You might also like
Depressions and their solution

Depressions and their solution

Following The Equator, Vol. 2 (The Writings of Mark Twain)

Following The Equator, Vol. 2 (The Writings of Mark Twain)

RACER # #2878530

RACER # #2878530

Se busca terreno para próxima barriada

Se busca terreno para próxima barriada

Ancient Monuments (Regional guides to ancient monuments, 4)

Ancient Monuments (Regional guides to ancient monuments, 4)

One Hundred Great Books

One Hundred Great Books

Price-setting oligopoly with customer search costs.

Price-setting oligopoly with customer search costs.

Consul in paradise

Consul in paradise

The drawings of Rembrandt.

The drawings of Rembrandt.

Who was who in America

Who was who in America

Travels in the Congo.

Travels in the Congo.

Just Walk Across the Room

Just Walk Across the Room

Betrothed

Betrothed

Basketball legends

Basketball legends

Between the foothills and the ridge

Between the foothills and the ridge

The Design of analgesic clinical trials Download PDF EPUB FB2

The Design of Analgesic Clinical Trials (Advances in Pain Research & Therapy): Medicine & Health Science Books @ ed by:   Pain research currently requires the skills of several basic and clinical disciplines.

This book is unique in its discussion of the elements of analgesic trial design. The editors are to be commended for the depth and breadth of its coverage. Its 63 authors were drawn from academia, industry, and government.

COVID Resources. Reliable information about the coronavirus (COVID) is available from the World Health Organization (current situation, international travel).Numerous and frequently-updated resource results are available from this ’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle.

The next several chapters explore a variety of clinical trials, from analgesic, antibiotic, and antiviral trials to cardiovascular and cancer prevention, prostate cancer, astrocytoma brain tumor, and chronic myelogonous leukemia trials.

The book then covers areas of drug development, medical practice, and safety assessment. Introduction. Clinical trials account for nearly 40% of the research and development budget of major pharmaceutical companies [], representing a major investment and consequently a significant hurdle to development of new sing efficiency early in treatment development could increase the number of approved pain therapies by allocating available Cited by: This book is an excellent introduction to clinical trials.

The chapters are brief, clearly explain the fundamentals and give some real examples. The book is easy to read, I would recommend it to people who are simply interested in this field and have no Cited by: Methodological Issues in the Design of Analgesic Clinical Trials Methodological Issues in the Design of Analgesic Clinical Trials Chapter: (p.3) 1 Methodological Issues in the Design of Analgesic Clinical Trials Source: Issues in Palliative Care Research Author(s): Russell K.

Portenoy Eduardo Bruera Publisher: Oxford University Press. PAracetamol and NSAID in Combination: A Randomised, Blinded, Parallel, 4-group Clinical Trial (PANSAID) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Georgia Southern University faculty member Karl E. Peace edited Design and Analysis of Clinical Trials with Time-to-Event Endpoints. He authored "Overview of Parametric based Inferential Methods for Time-to-Event Endpoints," "Overview of Time-to-Event Endpoint Methodology," and "Time-to-Event Endpoint Methods in Antibiotic Trials" in the by: 6.

A Q&A after PAINWeekwith PPM Board Member Srinivas Nalamachu, MD, of the Mid America PolyClinic, Kansas. Srinivas led a panel on modern analgesic trials at PAINWeek PPM: In general, how do analgesic trials differ from other more general drug trials.

Nalamachu: Primary endpoints in the clinical trials are mostly subjective with no objective. Analgesic trials pose unique scientific, ethical, and practical challenges in pediatrics. Participants in a scientific workshop sponsored by the US Food and Drug Administration developed consensus on aspects of pediatric analgesic clinical trial design.

The standard parallel-placebo analgesic trial design commonly used for adults has ethical Cited by:   Georgia Southern University faculty member Karl E.

Peace edited Design and Analysis of Clinical Trials with Time to Event Endpoints. Book Summary: Using time-to-event analysis methodology requires careful definition of the event, censored observation, provision of adequate follow-up, number of events, and independence or "noninformativeness" of the Cited by: 6.

The design of an analgesic clinical trial is usually of the following pattern; patients receive a single dose of an analgesic or a placebo after a pain-initiating event such as surgery, and pain. This is a single-center, randomized, double blind, placebo controlled, parallel group proof of concept study to evaluate the analgesic efficacy as well as the safety, tolerability and pharmacokinetic profile of CR in patients with pain following bunionectomy surgery.

A recent survey of analgesia clinical trial decision makers at 51 pharmaceutical and biotechnology firms in the United States and Europe demonstrated that nearly all respondents were likely or definitely going to use ePRO technology for future clinical trials.

8 The adoption of ePRO measures is based on the potential of its technology to reduce. number of trials of known efficacious treatments have also been negative, which raises questions about the ability of clinical trials to distinguish efficacious analgesic treatments from placebo or less efficacious treatments (i.e., assay sensitivity).

Patient characteristics, clinical trial designs, outcome measures, approaches to dataFile Size: KB. After reviewing time-to-event endpoint methodology, clinical trial issues, and the design and monitoring of clinical trials, the book focuses on inferential analysis methods, including parametric, semiparametric, categorical, and Bayesian methods; an alternative to the Cox model for small samples; and estimation and testing for change in : $ Pediatric Analgesic Clinical Trial Designs, Measures, and Extrapolation: Report of an FDA Scientific Workshop Article in PEDIATRICS (2) February with Reads How we measure 'reads'.

The shortcomings of randomized clinical trials are currently discussed along with potential improvements of trial designs. In this review we explain how utilizing knowledge from the placebo and nocebo mechanisms literature could improve the information that can be obtained from randomized clinical by: Dr.

Cooper is most well-known as the developer of the Dental Impaction Pain Model, one of the most widely used pain models in the world. He has published in peer reviewed journals over clinical papers on a wide variety of analgesic drugs.

His major areas of expertise are clinical trial design, analgesic drugs and development of consumer. The author takes a back-to-basics approach to explaining statistics specifically for a medically literate audience. Each article provides essential background information to each topic, explores its meaning, and explains how and when it should be applied.

Medical students, statistics students, clinical researchers, pharmaceutical sales representatives Statistics are complicated, 5/5(1).cluding pharmacokinetic–pharmacodynamic (PK-PD) trials, and the value of including both placebo and active standards of comparison in acute pain trials.

This article focuses on single-dose and short-duration trials with emphasis on the perioperative and study design factors that influence assay sensitivity.

Recommendations are presented on assessment measures, study .ISBN: OCLC Number: Description: 1 online resource (xvii, pages): illustrations. Contents: Overview of time-to-event endpoint methodology / Karl E.

Peace --Design (and monitoring) of clinical trials with time-to-event endpoints / Michael W. Sill and Larry Rubinstein --Overview of time-to-event parametric methods / Karl E. Peace and Kao .